Evidence of Antidepressant Harm that the FDA Sought to Suppress from FDA’s Public Advisory Committee Meeting on February 2

Evidence was presented on February 2 at AHRP’s press briefing by the following scientists:

AHRP’s written testimony: Where is the Scientific Evidence to Justify Exposing Children to the Risks of Antidepressant Drugs?

FDA Background Memorandum Jan 5, 2004, for Advisory Committee Meeting Re: Suicidality Associated with Antidepressant Drug Treatment.

AHRP correspondence with FDA demonstrating that the FDA would not permit this evidence to be presented at the public hearing:

Feb. 19. Dr. David Healy letter to FDA: updated suicidal evidence not addressed by FDA